CURING KIDNEY DISEASE THROUGH INNOVATIVE PERSONALIZED MEDICINE
To be a nationally and internationally recognized leader in pioneering patient-oriented research
To advance patient-oriented research that prevents or cures kidney disease and its complications through innovative personalized medicine
In recent years, tremendous advances in molecular biology and diagnostic technologies have provided new insights into the mechanisms of human disease. During the same period, the use of sophisticated statistical and computer-based techniques has allowed generation of further hypotheses relevant to human disease. The translation of these advances into a better understanding of human pathophysiology requires a unique set of skills from the clinical investigators. The broad aim of the Clinical and Translational Research Program is to provide investigators a platform for the design, execution, and interpretation of basic and specialized protocols and procedures for conducting clinical translational and epidemiological experiments.